As the industry continues shifting toward sustainable, animal-free endotoxin and microbial detection solutions, QC microbiology teams are increasingly asked to evaluate recombinant reagents for use in regulated environments. Yet, with diverse rFC reagent formats, manufacturers, and performance claims varying widely, many labs are left asking the same questions: Where do I start? What should I test? And how do I know whether a recombinant reagent is truly suitable for my process?

In this webinar, Puja Sawhney will share a first-hand look at a structured evaluation study designed to compare several recombinant reagent options currently available on the market. Attendees will gain a clear, science-driven understanding of how the study was designed, which variables were controlled, and what practical considerations shaped the experimental approach – from sample selection and matrix challenges to sensitivity expectations and data-quality criteria.

The session will walk through:

• Experiment design: Key parameters, rationale, and test conditions that mirror real QC workflows.
• Critical considerations: What matters most when planning a head-to-head reagent evaluation, including controls, interference risks, reagent stability, and lot-to-lot behavior.
• Results & observations: What performed well, what didn’t, and why – shared with transparency to help labs avoid common evaluation pitfalls.
• Actionable guidance: Recommendations to help QC microbiologists and analysts design their own successful evaluations, interpret results effectively, and set realistic expectations for recombinant reagent adoption.
  
  

Who should attend

This webinar is ideal for scientists, analysts, and leaders in:

• QC microbiology
• Pharmaceutical and biopharmaceutical manufacturing
• Biotechnology
• Cell & gene therapy
• CDMOs evaluating recombinant technologies for their workflows
  
  

Whether you are preparing to run your first recombinant reagent comparison or refining an existing evaluation strategy, this session will provide practical, lab-tested insights to help you make confident, evidence-based decisions.